(media)

Science, pharmaceutical assets, and innovation in motion.

Insights from the Aether team and press coverage of the platform, its projects, and the pharmaceutical development ecosystem.

Steel arch bridge over a river valley at dawn

Blog

Why a good technology alone does not attract investment

Between scientific discovery and investment lies an asset development gap. That is where good Brazilian technologies get stuck.

29 Jul 2026

Intellectual property as economic infrastructure in pharmaceutical innovation

Blog

Intellectual property isn't just protection. It's economic infrastructure.

In the pharmaceutical industry, intellectual property is no longer just an isolated legal instrument. It has become the mechanism that turns knowledge into a strategic asset, capable of attracting investment and generating technological sovereignty.

13 Jul 2026

Pharmaceutical capsule over a global map with market data

Blog

The biosimilar void and the window Brazil can't afford to ignore

The global pharmaceutical industry is facing one of the largest patent-exclusivity loss cycles in its history. Ninety percent of the opportunities opening up still have no competitors in development. What does that mean for Brazilian science?

30 Jun 2026

Aether Global Pharma team visiting UE FarmaVax

PressExternal link

UE FarmaVax hosts a visit from Aether Global Pharma

The post highlights Aether's visit to UE FarmaVax, covering an exchange on capabilities, infrastructure, projects, technologies, and intellectual property assets.

25 Jun 2026LinkedIn - UE Farmavax

Representation of South America in a pharmaceutical research setting

Blog

Brazil doesn't lack science. It lacks scientific assets.

A reflection on intellectual property, scientific assets, and Brazil's challenge of turning knowledge into economic value and technological sovereignty.

18 Jun 2026

Representatives at a Ministry of Health event on diagnosing and treating rare diseases within SUS

PressExternal link

With EMBRAPII's support, Ministry of Health announces initiatives to fight cancer, multiple sclerosis, and diabetes

Official EMBRAPII coverage of the R$90 million investment in advanced therapies, diagnostics, and strategic medicines for Brazil's public health system (SUS).

26 Feb 2026EMBRAPII

Woman embracing a child in an environment with plants

PressExternal link

Ministry of Health announces R$90 million for Brazil's SUS projects to fight cancer and diabetes

Report from the Painel column on the partnership between the Ministry of Health and EMBRAPII to expand access to advanced therapies and strategic medicines.

26 Feb 2026Folha de S.Paulo

Alexandre Padilha at a Ministry of Health event

PressExternal link

Ministry of Health launches R$90 million package to fight cancer, diabetes, and multiple sclerosis in Brazil's SUS

The piece highlights the package of public and private resources to develop advanced therapies, biopharmaceuticals, and diagnostic technologies in the country.

26 Feb 2026Agenda do Poder